Linezolid-induced serotonin syndrome
- PMID: 34158725
- PMCID: PMC8188929
- DOI: 10.4103/ipj.ipj_37_19
Linezolid-induced serotonin syndrome
Abstract
Linezolid is an oxazolidinone antibiotic, which is a weak, reversible, nonselective monoamine oxidase A and B inhibitor; is known to increase serotonin levels, and has been implicated in the development of serotonin syndrome (SS). There is limited literature on the development of SS with linezolid, when used alone. In this report, we present the case of a 70-year-old female who developed features of SS while being treated with linezolid 600 mg twice daily for pneumonia. The SS in her case was managed with stoppage of linezolid, administration of cyproheptadine, and supportive measures.
Keywords: Delirium; linezolid; serotonin syndrome.
Copyright: © 2021 Industrial Psychiatry Journal.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20. - PubMed
-
- Butterfield JM, Lawrence KR, Reisman A, Huang DB, Thompson CA, Lodise TP. Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data. J Antimicrob Chemother. 2012;67:494–502. - PubMed
-
- Frykberg RG, Gordon S, Tierney E, Banks J. Linezolid-associated serotonin syndrome. A Report of two cases. J Am Podiatr Med Assoc. 2015;105:244–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources